| Hydrophobically modified hydroxyethyl starch: synthesis, characterization, and aqueous self-assembly into nano-sized polymeric micelles and vesicles A Besheer, G Hause, J Kressler, K Mäder Biomacromolecules 8 (2), 359-367, 2007 | 184 | 2007 |
| Characterization of PLGA nanospheres stabilized with amphiphilic polymers: hydrophobically modified hydroxyethyl starch vs pluronics A Besheer, J Vogel, D Glanz, J Kressler, T Groth, K Mäder Molecular pharmaceutics 6 (2), 407-415, 2009 | 111 | 2009 |
| Influence of particle geometry and PEGylation on phagocytosis of particulate carriers R Mathaes, G Winter, A Besheer, J Engert International Journal of Pharmaceutics 465 (1-2), 159-164, 2014 | 95 | 2014 |
| Protein HESylation for half-life extension: synthesis, characterization and pharmacokinetics of HESylated anakinra R Liebner, R Mathaes, M Meyer, T Hey, G Winter, A Besheer European Journal of Pharmaceutics and Biopharmaceutics 87 (2), 378-385, 2014 | 94 | 2014 |
| Controlled shielding and deshielding of gene delivery polyplexes using hydroxyethyl starch (HES) and alpha-amylase M Noga, D Edinger, W Rödl, E Wagner, G Winter, A Besheer Journal of Controlled Release 159 (1), 92-103, 2012 | 93 | 2012 |
| The effect of molar mass and degree of hydroxyethylation on the controlled shielding and deshielding of hydroxyethyl starch-coated polyplexes M Noga, D Edinger, R Kläger, SV Wegner, JP Spatz, E Wagner, G Winter, ... Biomaterials 34 (10), 2530-2538, 2013 | 85 | 2013 |
| Comparative Investigations on In Vitro Serum Stability of Polymeric Micelle Formulations T Miller, R Rachel, A Besheer, S Uezguen, M Weigandt, A Goepferich Pharmaceutical research 29, 448-459, 2012 | 84 | 2012 |
| Non-spherical micro-and nanoparticles: fabrication, characterization and drug delivery applications R Mathaes, G Winter, A Besheer, J Engert Expert opinion on drug delivery 12 (3), 481-492, 2015 | 75 | 2015 |
| Enzymatically catalyzed HES conjugation using microbial transglutaminase: Proof of feasibility A Besheer, TC Hertel, J Kressler, K Mäder, M Pietzsch Journal of pharmaceutical sciences 98 (11), 4420-4428, 2009 | 74 | 2009 |
| Loading and mobility of spin-labeled insulin in physiologically responsive complexation hydrogels intended for oral administration A Besheer, KM Wood, NA Peppas, K Mäder Journal of Controlled Release 111 (1-2), 73-80, 2006 | 69 | 2006 |
| Physico-chemical characterization of polysaccharide-coated nanoparticles C Lemarchand, R Gref, S Lesieur, H Hommel, B Vacher, A Besheer, ... Journal of controlled Release 108 (1), 97-111, 2005 | 66 | 2005 |
| The role of polysorbate 80 and HPβCD at the air-water interface of IgG solutions T Serno, E Härtl, A Besheer, R Miller, G Winter Pharmaceutical research 30, 117-130, 2013 | 54 | 2013 |
| Application of different analytical methods for the characterization of non-spherical micro-and nanoparticles R Mathaes, G Winter, J Engert, A Besheer International journal of pharmaceutics 453 (2), 620-629, 2013 | 50 | 2013 |
| Influence of particle size, an elongated particle geometry, and adjuvants on dendritic cell activation R Mathaes, G Winter, TJ Siahaan, A Besheer, J Engert European Journal of Pharmaceutics and Biopharmaceutics 94, 542-549, 2015 | 35 | 2015 |
| Calculation of injection forces for highly concentrated protein solutions I Fischer, A Schmidt, A Bryant, A Besheer International journal of pharmaceutics 493 (1-2), 70-74, 2015 | 32 | 2015 |
| Head to head comparison of the formulation and stability of concentrated solutions of HESylated versus PEGylated anakinra R Liebner, M Meyer, T Hey, G Winter, A Besheer Journal of Pharmaceutical Sciences 104 (2), 515-526, 2015 | 32 | 2015 |
| Tracking the urinary excretion of high molar mass poly (vinyl alcohol) A Besheer, K Mäder, S Kaiser, J Kressler, C Weis, EK Odermatt Journal of Biomedical Materials Research Part B: Applied Biomaterials: An …, 2007 | 30 | 2007 |
| Evaluation of different quality-relevant aspects of closed system transfer devices (CSTDs) A Besheer, HC Mahler, A Matter-Schwald, SM Barrenechea, M Vogt, ... Pharmaceutical Research 37, 1-12, 2020 | 29 | 2020 |
| Influence of hydroxypropyl‐beta‐cyclodextrin on the stability of dilute and highly concentrated immunoglobulin G formulations E Härtl, G Winter, A Besheer Journal of Pharmaceutical Sciences 102 (11), 4121-4131, 2013 | 28 | 2013 |
| Weak antibody–cyclodextrin interactions determined by quartz crystal microbalance and dynamic/static light scattering E Härtl, N Dixit, A Besheer, D Kalonia, G Winter European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 781-789, 2013 | 28 | 2013 |
Robert Liebner在 sanofi.com 的电子邮件经过验证
